BRK-B vs ENVA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
With a Piotroski F-Score of 4/9 (Stable) and a current price of $166.65 positioned between the Graham Number ($124.67) and a high Intrinsic Value ($362.26), ENVA presents a strong value-growth opportunity. The company demonstrates exceptional fundamental momentum with YoY earnings growth of 28.6% and a highly attractive forward P/E of 8.67. While insider sentiment is bearish and technical trends are currently weak, the high ROE (25.13%) and a long track record of earnings beats provide a significant safety margin. The high debt-to-equity ratio is typical for the credit services industry and is mitigated by an exceptionally strong current ratio of 22.71.
Compare Another Pair
Related Comparisons
BRK-B vs ENVA: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Enova International, Inc. (ENVA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.